CVI Pharmaceuticals

CVI Pharmaceuticals Limited is a biopharmaceutical company with the mission to discover, develop, and commercialize first-in-class small molecule oral drugs targeting hypercholesterolemia, NAFLD, and NASH. CVI Pharmaceuticals, a clinical-stage company with offices and research facilities in California, USA, and Shanghai, China, is committed to scientific innovation through the integration of molecular biology, functional genomics, pharmacology, physiology, and medicinal chemistry.